Systematic review and network meta-analysis of interventions for adults with simple obesity: Study protocol.

Authors

Lingyao Sun, Lizhen Xu, Dachuang Zhou, Jun Wang, Xuan Yin, Wentao Ye, Lei Tian

Published in

PloS one. Volume 21. Issue 10. Pages e0351589. Epub Oct 08, 2026.

Abstract

Obesity has become a major global public health challenge, and its rising prevalence contributes to substantial health and economic burdens. Existing systematic reviews are largely confined to a single intervention category or to mixed populations, which limits targeted recommendations for adults in whom obesity itself, rather than an established metabolic comorbidity, is the principal clinical concern. This protocol describes a systematic review and network meta-analysis comparing dietary, physical activity, behavioural and pharmacological interventions in adults with simple obesity, pragmatically defined as trial populations in which obesity itself is the primary inclusion criterion. We will search PubMed, Embase and the Cochrane Library from inception to the search date for randomised controlled trials. Two reviewers will independently screen records, extract data and assess risk of bias using the Cochrane Risk of Bias 2 tool. The principal primary outcome will be percentage change in body weight at the end of an intervention period of at least 24 weeks. Key secondary outcomes will include the proportion of participants achieving at least 5% weight loss, separate measures of central obesity, and health-related quality of life. Pairwise and network meta-analyses will be conducted under a frequentist random-effects framework, and small-study effects will be examined with funnel plots and regression-based tests. Subgroup analyses and meta-regression will explore prespecified effect modifiers, and the credibility of important subgroup findings will be judged with the ICEMAN instrument. Certainty of evidence will be assessed using the GRADE framework. Depending on the quality, consistency and certainty of the available evidence, the findings may inform clinical decision-making, future guideline development and research priorities. This review is registered with PROSPERO (CRD420251236477).

PMID:
42848776
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.